Randomised controlled trial for high-dose intravenous zinc as adjunctive therapy in SARS-CoV-2 (COVID-19) positive critically ill patients: trial protocol

INTRODUCTION: SARS-CoV-2 (COVID-19) has caused an international pandemic of respiratory illness, resulting in significant healthcare and economic turmoil. To date, no robust vaccine or treatment has been identified. Elemental zinc has previously been demonstrated to have beneficial effects on corona...

Descripción completa

Detalles Bibliográficos
Autores principales: Perera, Marlon, El Khoury, John, Chinni, Vidyasagar, Bolton, Damien, Qu, Liang, Johnson, Paul, Trubiano, Jason, McDonald, Christine F, Jones, Daryl, Bellomo, Rinaldo, Patel, Oneel, Ischia, Joseph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Infectious Diseases
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7712927/
https://www.ncbi.nlm.nih.gov/pubmed/33268419
http://dx.doi.org/10.1136/bmjopen-2020-040580

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7712927/
https://www.ncbi.nlm.nih.gov/pubmed/33268419
http://dx.doi.org/10.1136/bmjopen-2020-040580

Ejemplares similares